Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 27

    1.

    Hematologic features of hepatosplenic T-cell lymphoma.

    Erber WN, Finlayson J.

    Am J Clin Pathol. 2012 Feb;137(2):334-5. No abstract available.

    PMID:
    22261460
    [PubMed - indexed for MEDLINE]
    2.

    The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies.

    Ji M, Rao E, Ramachandrareddy H, Shen Y, Jiang C, Chen J, Hu Y, Rizzino A, Chan WC, Fu K, McKeithan TW.

    Am J Pathol. 2011 Oct;179(4):1645-56. Epub 2011 Jul 30.

    PMID:
    21806958
    [PubMed - indexed for MEDLINE]
    3.

    How I treat enteropathy-associated T-cell lymphoma.

    Di Sabatino A, Biagi F, Gobbi PG, Corazza GR.

    Blood. 2012 Mar 15;119(11):2458-68. Epub 2012 Jan 23.

    PMID:
    22271451
    [PubMed - indexed for MEDLINE]
    4.

    Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.

    Gupta P, Goldenberg DM, Rossi EA, Cardillo TM, Byrd JC, Muthusamy N, Furman RR, Chang CH.

    Blood. 2012 Apr 19;119(16):3767-78. Epub 2012 Jan 23.

    PMID:
    22271448
    [PubMed - in process]
    6.

    Acquired STAT4 deficiency as a consequence of cancer chemotherapy.

    Lupov IP, Voiles L, Han L, Schwartz A, De La Rosa M, Oza K, Pelloso D, Sahu RP, Travers JB, Robertson MJ, Chang HC.

    Blood. 2011 Dec 1;118(23):6097-106. Epub 2011 Oct 13.

    PMID:
    21998209
    [PubMed - indexed for MEDLINE]
    7.

    Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.

    Tennis P, Gelfand JM, Rothman KJ.

    Br J Dermatol. 2011 Sep;165(3):465-73. doi: 10.1111/j.1365-2133.2011.10363.x. Epub 2011 Jun 30. Review.

    PMID:
    21466537
    [PubMed - indexed for MEDLINE]
    8.

    Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.

    Miles RR, Arnold S, Cairo MS.

    Br J Haematol. 2012 Mar;156(6):730-43. doi: 10.1111/j.1365-2141.2011.09024.x. Epub 2012 Jan 20. Review.

    PMID:
    22260323
    [PubMed - indexed for MEDLINE]
    9.

    Epidemiology: clues to the pathogenesis of Burkitt lymphoma.

    Magrath I.

    Br J Haematol. 2012 Mar;156(6):744-56. doi: 10.1111/j.1365-2141.2011.09013.x. Epub 2012 Jan 20. Review.

    PMID:
    22260300
    [PubMed - indexed for MEDLINE]
    10.

    [Recurrent hypoglycemia and a large intraabdominal tumor in a 61-year-old woman].

    Kahl C, Jost K, Knauerhase A, Leithäuser M, Freund M, Bunke D, Rothacker D, Hampel R.

    Dtsch Med Wochenschr. 2011 Dec;136(49):2542-6. Epub 2011 Nov 30. German.

    PMID:
    22131074
    [PubMed - indexed for MEDLINE]
    11.

    Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.

    Persky DO, Dornan D, Goldman B, Braziel R, Fisher R, Leblanc M, Maloney DG, Press O, Miller T, Rimsza LM.

    Haematologica. 2012 Jan 22. [Epub ahead of print]

    PMID:
    22271896
    [PubMed - as supplied by publisher]
    Free Article
    12.

    Positron emission tomography response at time of autologous stem cell transplantation predict outcome of patients with relapsed and/or refractory Hodgkin Lymphoma responding to prior salvage therapy.

    Devillier R, Coso D, Castagna L, Brenot Rossi I, Anastasia A, Chiti A, Ivanov V, Schiano JM, Santoro A, Chabannon C, Balzarotti M, Blaise D, Bouabdallah R.

    Haematologica. 2012 Jan 22. [Epub ahead of print]

    PMID:
    22271893
    [PubMed - as supplied by publisher]
    Free Article
    13.

    Over-expression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.

    Uddin S, Hussain AR, Ahmed M, Siddiqui K, Al-Dayel F, Bavi P, Al-Kuraya KS.

    Haematologica. 2012 Jan 22. [Epub ahead of print]

    PMID:
    22271891
    [PubMed - as supplied by publisher]
    Free Article
    14.

    Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis.

    Becker N, Falster MO, Vajdic CM, de Sanjose S, Martínez-Maza O, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner J, Vineis P, Costantini AS, Holly EA, Spinelli JJ, La Vecchia C, Zheng T, Chiu BC, Montella M, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE, Newton R.

    Int J Cancer. 2012 Jan 21. doi: 10.1002/ijc.27438. [Epub ahead of print]

    PMID:
    22266776
    [PubMed - as supplied by publisher]
    15.

    Risk of Developing Cardiovascular Disease after Involved Node Radiotherapy versus Mantle Field for Hodgkin Lymphoma.

    Maraldo MV, Brodin NP, Vogelius IR, Aznar MC, Munck Af Rosenschöld P, Petersen PM, Specht L.

    Int J Radiat Oncol Biol Phys. 2012 Jan 21. [Epub ahead of print]

    PMID:
    22270170
    [PubMed - as supplied by publisher]
    16.

    Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German hodgkin study group HD14 trial.

    von Tresckow B, Plütschow A, Fuchs M, Klimm B, Markova J, Lohri A, Kral Z, Greil R, Topp MS, Meissner J, Zijlstra JM, Soekler M, Stein H, Eich HT, Mueller RP, Diehl V, Borchmann P, Engert A.

    J Clin Oncol. 2012 Mar 20;30(9):907-13. Epub 2012 Jan 23.

    PMID:
    22271480
    [PubMed - indexed for MEDLINE]
    17.

    Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

    Coiffier B, Pro B, Prince HM, Foss F, Sokol L, Greenwood M, Caballero D, Borchmann P, Morschhauser F, Wilhelm M, Pinter-Brown L, Padmanabhan S, Shustov A, Nichols J, Carroll S, Balser J, Balser B, Horwitz S.

    J Clin Oncol. 2012 Feb 20;30(6):631-6. Epub 2012 Jan 23.

    PMID:
    22271479
    [PubMed - indexed for MEDLINE]
    18.

    MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

    McPhee CG, Sproule TJ, Shin DM, Bubier JA, Schott WH, Steinbuck MP, Avenesyan L, Morse HC 3rd, Roopenian DC.

    J Immunol. 2011 Nov 1;187(9):4695-704. Epub 2011 Sep 30.

    PMID:
    21964024
    [PubMed - indexed for MEDLINE]
    19.

    Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.

    Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22273250
    [PubMed - as supplied by publisher]
    20.

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk